Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Scanning with L-(/sup 13/N) glutamate: Assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma

Journal Article · · Am. J. Clin. Oncol.; (United States)
OSTI ID:7070830
The use of /sup 13/N-labeled L-glutamate as an imaging agent in a patient with embryonal rhabdomyosarcoma is described. Localization of /sup 13/N in a large, poorly defined tumor of the left pectoral region was seen, and clinically occult right axilliary metastases were also detected. A marked reduction in uptake in these areas occurred after chemotherapy, paralleling the clinical disappearance of tumor. These changes were verified on gallium scan. /sup 13/N-labeled glutamate may be useful as an imaging agent, especially in patients with soft-tissue sarcomas.
Research Organization:
The Memorial Sloan-Kettering Cancer Center, Cornell University School of Medicine, New York
OSTI ID:
7070830
Journal Information:
Am. J. Clin. Oncol.; (United States), Journal Name: Am. J. Clin. Oncol.; (United States) Vol. 5:3; ISSN AJCOD
Country of Publication:
United States
Language:
English